Skip to content
10-K

Annual Report

FRESH TRACKS THERAPEUTICS, INC.

0001628280-24-011460

← back to feed
Filed
Mar 15, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 15, 2024 5.97M sh
Shares Diluted FY 2023 · Dec 31, 2023 5.39M sh
Shares Diluted FY 2023 · Dec 31, 2022 2.81M sh
Operating Cash Flow FY 2023 · Dec 31, 2023 −$4.34M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$19.34M
Cash And Equivalents FY 2023 · Dec 31, 2023 $10.87M
Cash And Equivalents FY 2023 · Dec 31, 2022 $8.68M
Stockholders Equity FY 2023 · Dec 31, 2023 $9.93M
Stockholders Equity FY 2023 · Dec 31, 2022 $7.19M
Stockholders Equity FY 2023 · Dec 31, 2021 $24.91M
Current Liabilities FY 2023 · Dec 31, 2023 $1.66M
Current Liabilities FY 2023 · Dec 31, 2022 $3.08M
Current Assets FY 2023 · Dec 31, 2023 $11.55M
Current Assets FY 2023 · Dec 31, 2022 $10.08M
Total Assets FY 2023 · Dec 31, 2023 $11.59M
Total Assets FY 2023 · Dec 31, 2022 $10.27M
Eps Diluted FY 2023 · Dec 31, 2023 −$1.06
Eps Diluted FY 2023 · Dec 31, 2022 −$7.51
Eps Basic FY 2023 · Dec 31, 2023 −$1.06
Eps Basic FY 2023 · Dec 31, 2022 −$7.51
Sga Expense FY 2023 · Dec 31, 2023 $11.18M
Sga Expense FY 2023 · Dec 31, 2022 $14.43M
Rd Expense FY 2023 · Dec 31, 2023 $3.18M
Rd Expense FY 2023 · Dec 31, 2022 $14.04M
Net Income FY 2023 · Dec 31, 2023 −$5.69M
Net Income FY 2023 · Dec 31, 2022 −$21.1M
Operating Income FY 2023 · Dec 31, 2023 −$6.36M
Operating Income FY 2023 · Dec 31, 2022 −$21.53M
Revenue FY 2023 · Dec 31, 2023 $8.01M
Revenue FY 2023 · Dec 31, 2022 $6.94M